Abstract

BackgroundNanocolloidal human serum albumin radiolabelled with 99mTc provides a diagnostic radiopharmaceutical for sentinel node lymphoscintigraphy. NanoHSA (Nanotop), a commercially available kit, enables the simple preparation of this radiopharmaceutical via reconstitution with pertechnetate eluted from a generator. Thin-layer chromatography is widely used for determining radiochemical purity in clinical nuclear medicine. Quality control methods recommended by the manufacturer were sometimes reported to yield variable results. Therefore, we proposed and evaluated three alternative thin-layer chromatography methods for the quality control of [99mTc]Tc-NanoHSA from a commercially available kit.ResultsThe radiochemical purity of [99mTc]Tc-NanoHSA determined with all methods was reproducible and met the requirements of the SPC and the European Pharmacopoeia (≥ 95%). Our quality control using iTLC-SG chromatographic paper in methyl ethyl ketone mobile phase identified only free pertechnetate as impurity, resulting in > 99% RCP. The quality control using iTLC-SG in 85% methanol or iTLC-SA in 0.9% NaCl identified an additional small fraction of a hydrophilic impurity, resulting in 95–97% RCP. Glucose was identified as a potential 99mTc-carrying hydrophilic species contributing to hydrophilic impurities.ConclusionOur quality control of [99mTc]Tc-NanoHSA with non-polar mobile phase tended to underestimate the amount of hydrophilic impurities, although without compromising the final quality of the radiopharmaceutical. Alternative TLC methods using aqueous mobile phases enabled a more accurate determination of hydrophilic impurities.

Highlights

  • Human serum albumin (HSA) is the most abundant protein in the blood serum and is readily radiolabelled with 99mTc

  • Effect of needle gauge on Thin-layer chromatography (TLC) performance To determine the size of a drop deposited for thin-layer chromatography using a syringe, we tested a range of needles of different diameters routinely used for the quality control (QC) of radiopharmaceuticals in clinical nuclear medicine

  • The quality control of a commercially available NanoHSA kit labelled with 99mTc showed a reproducible radiochemical purity (RCP) that fulfilled the criteria of the summary of product characteristics (SPC), and the minimal 95% RCP requirement recommended by the European Pharmacopoeia for 99mTc-radiopharmaceuticals

Read more

Summary

Introduction

Human serum albumin (HSA) is the most abundant protein in the blood serum and is readily radiolabelled with 99mTc (technetium-99m). 50–80 nm HSA nanoparticles labelled with 99mTc provide a diagnostic radiopharmaceutical agent for sentinel lymph nodes scintigraphy (Giammarile et al.2013; Sadkin et al 2020). Since the radiopharmaceutical is prepared shortly prior to administration, a quality control (QC) must be performed immediately after radiolabelling in order to determine the radiochemical purity (RCP). Thin-layer chromatography (TLC) is the most widely used method for QC of radiopharmaceuticals prepared from commercially available kits. Nanocolloidal human serum albumin radiolabelled with 99mTc provides a diagnostic radiopharmaceutical for sentinel node lymphoscintigraphy. NanoHSA (Nanotop), a commercially available kit, enables the simple preparation of this radiopharmaceutical via reconstitution with pertechnetate eluted from a generator. We proposed and evaluated three alternative thin-layer chromatography methods for the quality control of ­[99mTc] Tc-NanoHSA from a commercially available kit

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.